IL-1 induces LIF expression and downstream JAK/STAT activation to generate inflammatory CAFs in pancreatic cancer, thus promoting cancer progression, chemoresistance and other cancer-associated systemic effects, such as cachexia and immune suppression (45). The gene discussed is IL1A; the disease is cancer.